Attached files
file | filename |
---|---|
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC. | exhibit311q32018.htm |
EX-99.1 - CERTAIN LITIGATION MATTERS - ALTRIA GROUP, INC. | exhibit991q32018.htm |
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC. | exhibit322q32018.htm |
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC. | exhibit321q32018.htm |
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC. | exhibit312q32018.htm |
EX-12 - STATEMENT REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES - ALTRIA GROUP, INC. | exhibit12computationofrati.htm |
10-Q - FORM 10-Q - ALTRIA GROUP, INC. | a2018form10qq32018.htm |
Exhibit 99.2
TRIAL SCHEDULE FOR CERTAIN CASES
Below is a schedule, as of October 22, 2018 setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for trial through December 31, 2018.
2018
Engle progeny
October | 1 |
November | 4 |
December | 0 |
As of October 22, 2018, there are no Engle progeny cases in trial.
Other Individual Smoking & Health
October | 1 |
November | 0 |
December | 1 |
As of October 22, 2018, there are no non-Engle progeny cases in trial.